Summit Therapeutics Reports Q4 and 2024 Full-Year Financial and Operational Results Summit Therapeutics Inc. (NASDAQ: SMMT) has provided an update on its operational progress and financial results for the fourth…
Celltrion Gets EC Approval for Avtozma® (CT-P47), Biosimilar to RoActemra® Celltrion announced today that it has received marketing authorization from the European Commission (EC) for Avtozma® (CT-P47), a biosimilar referencing…
KalVista to Present New Sebetralstat Data at AAAAI 2025 Annual Meeting KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) has announced that six of its abstracts have been accepted for presentation at the…
Covalon Reports Fourth Straight Quarter of Revenue Growth and Positive Earnings Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its financial results for the…
Waystar Prices Public Offering of Common Stock Waystar Holding Corp. (Nasdaq: WAY), a leader in healthcare payments software, announced the pricing of its underwritten public offering of 20,000,000 shares of…
AMN Healthcare Reports Q4 and Full Year 2024 Results AMN Healthcare Services, Inc. (NYSE: AMN), a leader in total talent solutions for healthcare organizations across the U.S., has announced its…
Variational AI Raises $5.5 Million to Launch Foundation Model for Drug Discovery Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, has successfully closed…
DocGo Expands into Chattanooga Region in Collaboration with Major Tennessee Healthcare System DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced…
Reverb Therapeutics Secures $12M to Advance Amplify•R™ Platform Reverb Therapeutics, a leader in harnessing the natural immune system and cytokine signaling to treat life-threatening diseases, announced it has closed a…
Oneview Healthcare Launches ‘Ovie’ Care Assistant to Ease Nursing Burden Oneview Healthcare has launched Ovie, a groundbreaking GenAI product designed to offer personalized, real-time support for patients and their families…
GeneDx Reports Q4 and 2024 Financial Results, Provides 2025 Guidance GeneDx Holdings Corp. (Nasdaq: WGS), a leader in genomic testing for improved health outcomes, reported its financial results for the…
Cellistic Unveils Allo Chassis™: Immune-Cloaked iPSC Cell Lines for Cost-Effective Cell Therapy Cellistic, a leader in iPSC-based off-the-shelf cell therapy development and manufacturing services, has introduced its innovative Allo Chassis™—a…